ArticleBreast cancer : basic and clinical research2025

Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World Setting.

Karen Gambaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.